IMMG Share Price Performance
US$0.000001
0.00 (0.00%)
Price US$0.000001
Share PriceUS$0.000001
IMMG Community Narratives
There are no narratives available yet.
Recent IMMG News & Updates
No updates
Immage Biotherapeutics Corp. Key Details
Last Reported Earnings
Feb 28, 2017
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Immage Biotherapeutics Corp. Competitors
This week, we’re going to look at the U.S. regulatory changes, how adoption has been trending, and one of the risks with the ETFs. If you want some exposure to Bitcoin, at the end, we’ll show you some different ways you can position your portfolio accordingly.
Continue reading
About IMMG
- Founded
- 2012
- Employees
- n/a
- CEO
- WebsiteView website
Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.
U.S. Market Performance
- 7 Days: 1.3%
- 3 Months: 8.8%
- 1 Year: 15.8%
- Year to Date: 9.5%
The Healthcare and Consumer Discretionary sectors drove a 1.3% in the market over the last week. As for the past 12 months, the market is up 16%. Earnings are forecast to grow by 15% annually. Market details ›